Intellectual Property


Daniel Palmer is an associate in Brown Rudnick’s Intellectual Property practice. His practice is focused on patent prosecution, including the preparation of national and international patent applications and reports on patentability, infringement and validity.

Prior to attending law school, Daniel worked at the Research Institute for Children at Children’s Hospital, New Orleans, performing research into roles of G-protein mediated signal transduction in fungal pathogenesis.

Prior to joining Brown Rudnick, Daniel was an Associate at Campbell Campbell Edwards & Conroy, P.C., working on litigation in the areas of personal injury, contracts, patent infringement, civil rights, employment law, and products liability.


Northwestern University School of Law – J.D., 2009
Tulane University – B.S.E., 2003

Bar Admissions

Rhode Island
U.S. District Courts, District of Massachusetts and District of Rhode Island
U.S. Patent and Trademark Office
U.S. Supreme Court
Co-author, “Gib2, a novel Gbeta-like/RACK1 homolog function as a Gbeta subunit in cAMP signaling and is essential in Cryptococcus neoformans.” J. Biol. Chem. 281: 32596-605, 2006.
Co-author, “Mutation of the regulator of G protein signaling Crg1 increases virulence in Cryptococcus neoformans.” Eukaryot Cell. 2004 Aug;3(4):1028-35.